YahooSeptember 4, 2026 at 12:57 PM NY6 hours ago

Was JNJ Stock Rally Actually Its Own?

Johnson & Johnson (JNJ) stock returned 59.9% over the past year, against 21.1% for the S&P 500. The company has a clean story for it. The biosimilar hit it had been bracing for arrived and was absorbed, and its talc litigation now has a proposed ending. Both are real. The first does not explain a move that size, and the second is not finished.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

PFEPfizer Inc28.43− 1.32%

Companies in This Story

Related Stories